Hubbry Logo
Wound healingWound healingMain
Open search
Wound healing
Community hub
Wound healing
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Wound healing
Wound healing
from Wikipedia

Healing progression of a hand abrasion
Initial injury 3 days 17 days 30 days

Wound healing refers to a living organism's replacement of destroyed or damaged tissue by newly produced tissue.[1]

In undamaged skin, the epidermis (surface, epithelial layer) and dermis (deeper, connective layer) form a protective barrier against the external environment. When the barrier is broken, a regulated sequence of biochemical events is set into motion to repair the damage.[1][2] This process is divided into predictable phases: blood clotting (hemostasis), inflammation, tissue growth (cell proliferation), and tissue remodeling (maturation and cell differentiation). Blood clotting may be considered to be part of the inflammation stage instead of a separate stage.[3]

Healing progression of a deep laceration wound on the shin with sutures over a five-week period.

The wound-healing process is not only complex but fragile, and it is susceptible to interruption or failure leading to the formation of non-healing chronic wounds. Factors that contribute to non-healing chronic wounds are diabetes, venous or arterial disease, infection, and metabolic deficiencies of old age.[4]

Wound care encourages and speeds wound healing via cleaning and protection from reinjury or infection. Depending on each patient's needs, it can range from the simplest first aid to entire nursing specialties such as wound, ostomy, and continence nursing and burn center care.

Stages

[edit]
  • Hemostasis (blood clotting): Within the first few minutes of injury, platelets in the blood begin to stick to the injured site. They change into an amorphous shape, more suitable for clotting, and they release chemical signals to promote clotting. This results in the activation of fibrin, which forms a mesh and acts as "glue" to bind platelets to each other. This makes a clot that serves to plug the break in the blood vessel, slowing/preventing further bleeding.[5][6]
  • Inflammation: During this phase, damaged and dead cells are cleared out, along with bacteria and other pathogens or debris. This happens through the process of phagocytosis, where white blood cells engulf debris and destroy it. Platelet-derived growth factors are released into the wound that cause the migration and division of cells during the proliferative phase.
  • Proliferation (growth of new tissue): In this phase, angiogenesis, collagen deposition, granulation tissue formation, epithelialization, and wound contraction occur.[7] In angiogenesis, vascular endothelial cells form new blood vessels.[8] In fibroplasia and granulation tissue formation, fibroblasts grow and form a new, provisional extracellular matrix (ECM) by excreting collagen and fibronectin.[7] Concurrently, re-epithelialization of the epidermis occurs, in which epithelial cells proliferate and 'crawl' atop the wound bed, providing cover for the new tissue.[9] In wound contraction, myofibroblasts decrease the size of the wound by gripping the wound edges and contracting using a mechanism that resembles that in smooth muscle cells. When the cells' roles are close to complete, unneeded cells undergo apoptosis.[7]
  • Maturation (remodeling): During maturation and remodeling, collagen is realigned along tension lines, and cells that are no longer needed are removed by programmed cell death, or apoptosis.
Approximate times of the different phases of wound healing on a logarithmic scale,[10] with faded intervals marking substantial variation, depending mainly on wound size and healing conditions, but image does not include major impairments that cause chronic wounds.

Timing and re-epithelialization

[edit]

Timing is important to wound healing. Critically, the timing of wound re-epithelialization can decide the outcome of the healing.[11] If the epithelization of tissue over a denuded area is slow, a scar will form over many weeks, or months;[12][13] If the epithelization of a wounded area is fast, the healing will result in regeneration.[13]

Early vs cellular phase

[edit]
A fluorescence micrograph of cells in Drosophila larvae healing after a puncture wound. The arrow points to cells that have fused to form syncytia, and the arrowheads point to cells that are oriented to face the wound.[14]

Wound healing is classically divided into hemostasis, inflammation, proliferation, and remodeling. Although a useful construct, this model employs considerable overlapping among individual phases. A complementary model has recently been described[1] where the many elements of wound healing are more clearly delineated. The importance of this new model becomes more apparent through its utility in the fields of regenerative medicine and tissue engineering (see Research and development section below). In this construct, the process of wound healing is divided into two major phases: the early phase and the cellular phase:[1]

The early phase, which begins immediately following skin injury, involves cascading molecular and cellular events leading to hemostasis and formation of an early, makeshift extracellular matrix that provides structural staging for cellular attachment and subsequent cellular proliferation.

The cellular phase involves several types of cells working together to mount an inflammatory response, synthesize granulation tissue, and restore the epithelial layer.[1] Subdivisions of the cellular phase are:

  1. Macrophages and inflammatory components (within 1–2 days)
  2. Epithelial-mesenchymal interaction: re-epithelialization (phenotype change within hours, migration begins on day 1 or 2)
  3. Fibroblasts and myofibroblasts: progressive alignment, collagen production, and matrix contraction (between day 4 and day 14)
  4. Endothelial cells and angiogenesis (begins on day 4)
  5. Dermal matrix: elements of fabrication (begins on day 4, lasting 2 weeks) and alteration/remodeling (begins after week 2, lasting weeks to months—depending on wound size).[1]

Inflammatory phase

[edit]

Just before the inflammatory phase is initiated, the clotting cascade occurs in order to achieve hemostasis, or the stopping of blood loss by way of a fibrin clot. Thereafter, various soluble factors (including chemokines and cytokines) are released to attract cells that phagocytise debris, bacteria, and damaged tissue, in addition to releasing signaling molecules that initiate the proliferative phase of wound healing.

Clotting cascade

[edit]

When tissue is first wounded, blood comes in contact with collagen, triggering blood platelets to begin secreting inflammatory factors.[15] Platelets also express sticky glycoproteins on their cell membranes that allow them to aggregate, forming a mass.[7]

Fibrin and fibronectin cross-link together and form a plug that traps proteins and particles and prevents further blood loss.[16] This fibrin-fibronectin plug is also the main structural support for the wound until collagen is deposited.[7] Migratory cells use this plug as a matrix to crawl across, and platelets adhere to it and secrete factors.[7] The clot is eventually lysed and replaced with granulation tissue and then later with collagen.

Platelets, the cells present in the highest numbers shortly after a wound occurs, release mediators into the blood, including cytokines and growth factors.[15] Growth factors stimulate cells to speed their rate of division. Platelets release other proinflammatory factors like serotonin, bradykinin, prostaglandins, prostacyclins, thromboxane, and histamine,[3] which serve several purposes, including increasing cell proliferation and migration to the area and causing blood vessels to become dilated and porous. In many ways, extravasated platelets in trauma perform a similar function to tissue macrophages and mast cells exposed to microbial molecular signatures in infection: they become activated, and secrete molecular mediators – vasoactive amines, eicosanoids, and cytokines – that initiate the inflammatory process.

Vasoconstriction and vasodilation

[edit]

Immediately after a blood vessel is breached, ruptured cell membranes release inflammatory factors like thromboxanes and prostaglandins that cause the vessel to spasm to prevent blood loss and to collect inflammatory cells and factors in the area.[3] This vasoconstriction lasts five to ten minutes and is followed by vasodilation, a widening of blood vessels, which peaks at about 20 minutes post-wounding.[3] Vasodilation is the result of factors released by platelets and other cells. The main factor involved in causing vasodilation is histamine.[3][15] Histamine also causes blood vessels to become porous, allowing the tissue to become edematous because proteins from the bloodstream leak into the extravascular space, which increases its osmolar load and draws water into the area.[3] Increased porosity of blood vessels also facilitates the entry of inflammatory cells like leukocytes into the wound site from the bloodstream.[17][18]

Polymorphonuclear neutrophils

[edit]

Within an hour of wounding, polymorphonuclear neutrophils (PMNs) arrive at the wound site and become the predominant cells in the wound for the first two days after the injury occurs, with especially high numbers on the second day.[19] They are attracted to the site by fibronectin, growth factors, and substances such as kinins. Neutrophils phagocytise debris and kill bacteria by releasing free radicals in what is called a respiratory burst.[20][21] They also cleanse the wound by secreting proteases that break down damaged tissue. Functional neutrophils at the wound site only have life-spans of around two days, so they usually undergo apoptosis once they have completed their tasks and are engulfed and degraded by macrophages.[22]

Other leukocytes to enter the area include helper T cells, which secrete cytokines to cause more T cells to divide and to increase inflammation and enhance vasodilation and vessel permeability.[17][23] T cells also increase the activity of macrophages.[17]

Macrophages

[edit]

One of the roles of macrophages is to phagocytize other expended phagocytes,[24] bacteria and damaged tissue,[19] and they also debride damaged tissue by releasing proteases.[25]

Macrophages function in regeneration[26][27] and are essential for wound healing.[19] They are stimulated by the low oxygen content of their surroundings to produce factors that induce and speed angiogenesis[20] and they also stimulate cells that reepithelialize the wound, create granulation tissue, and lay down a new extracellular matrix.[28] By secreting these factors, macrophages contribute to pushing the wound healing process into the next phase. They replace PMNs as the predominant cells in the wound by two days after injury.[24]

The spleen contains half the body's monocytes in reserve ready to be deployed to injured tissue.[29][30] Attracted to the wound site by growth factors released by platelets and other cells, monocytes from the bloodstream enter the area through blood vessel walls.[31] Numbers of monocytes in the wound peak one to one and a half days after the injury occurs.[23] Once they are in the wound site, monocytes mature into macrophages. Macrophages also secrete a number of factors such as growth factors and other cytokines, especially during the third and fourth post-wounding days. These factors attract cells involved in the proliferation stage of healing to the area.[15]

In wound healing that result in incomplete repair, scar contraction occurs, bringing varying gradations of structural imperfections, deformities and problems with flexibility.[32] Macrophages may restrain the contraction phase.[27] Scientists have reported that removing the macrophages from a salamander resulted in failure of a typical regeneration response (limb regeneration), instead bringing on a repair (scarring) response.[33][34]

Decline of inflammatory phase

[edit]

As inflammation dies down, fewer inflammatory factors are secreted, existing ones are broken down, and numbers of neutrophils and macrophages are reduced at the wound site.[19] These changes indicate that the inflammatory phase is ending and the proliferative phase is underway.[19] In vitro evidence, obtained using the dermal equivalent model, suggests that the presence of macrophages actually delays wound contraction and thus the disappearance of macrophages from the wound may be essential for subsequent phases to occur.[27]

Because inflammation plays roles in fighting infection, clearing debris and inducing the proliferation phase, it is a necessary part of healing. However, inflammation can lead to tissue damage if it lasts too long.[7] Thus the reduction of inflammation is frequently a goal in therapeutic settings. Inflammation lasts as long as there is debris in the wound. Thus, if the individual's immune system is compromised and is unable to clear the debris from the wound and/or if excessive detritus, devitalized tissue, or microbial biofilm is present in the wound, these factors may cause a prolonged inflammatory phase and prevent the wound from properly commencing the proliferation phase of healing. This can lead to a chronic wound.

Proliferative phase

[edit]

About two or three days after the wound occurs, fibroblasts begin to enter the wound site, marking the onset of the proliferative phase even before the inflammatory phase has ended.[35] As in the other phases of wound healing, steps in the proliferative phase do not occur in a series but rather partially overlap in time.

Angiogenesis

[edit]

Also called neovascularization, the process of angiogenesis occurs concurrently with fibroblast proliferation when endothelial cells migrate to the area of the wound.[36] Because the activity of fibroblasts and epithelial cells requires oxygen and nutrients, angiogenesis is imperative for other stages in wound healing, like epidermal and fibroblast migration. The tissue in which angiogenesis has occurred typically looks red (is erythematous) due to the presence of capillaries.[36]

Angiogenesis occurs in overlapping phases in response to inflammation:

  1. Latent period: During the haemostatic and inflammatory phase of the wound healing process, vasodilation and permeabilisation allow leukocyte extravasation and phagocytic debridement and decontamination of the wound area. Tissue swelling aids later angiogenesis by expanding and loosening the existing collagenous extracellular matrix.
  2. Endothelial activation: As the wound macrophages switches from inflammatory to healing mode, it begins to secrete endothelial chemotactic and growth factors to attract adjacent endothelial cells. Activated endothelial cells respond by retracting and reducing cell junctions, loosening themselves from their embedded endothelium. Characteristically the activated endothelial cells show enlarged nucleoli.
  3. Degradation of endothelial basement membrane: The wound macrophages, mast cells and the endothelial cells themselves secrete proteases to break down existing vascular basal lamina.
  4. Vascular sprouting: With the breakdown of endothelial basement membrane, detached endothelial cells from pre-existing capillaries and post-capillary venules can divide and migrate chemotactically towards the wound, laying down new vessels in the process. Vascular sprouting can be aided by ambient hypoxia and acidosis in the wound environment, as hypoxia stimulates the endothelial transcription factor, hypoxia inducible factor (HIF) to transactivate angiogenic genes such as VEGF and GLUT1. Sprouted vessels can self-organise into luminal morphologies, and fusion of blind channels give rise to new capillary networks.
  5. Vascular maturation: the endothelium of vessels mature by laying down new endothelial extracellular matrix, followed by basal lamina formation. Lastly the vessel establishes a pericyte layer.

Stem cells of endothelial cells, originating from parts of uninjured blood vessels, develop pseudopodia and push through the ECM into the wound site to establish new blood vessels.[20]

Endothelial cells are attracted to the wound area by fibronectin found on the fibrin scab and chemotactically by angiogenic factors released by other cells,[37] e.g. from macrophages and platelets when in a low-oxygen environment. Endothelial growth and proliferation is also directly stimulated by hypoxia, and presence of lactic acid in the wound.[35] For example, hypoxia stimulates the endothelial transcription factor, hypoxia-inducible factor (HIF) to transactivate a set of proliferative genes including vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT1).

To migrate, endothelial cells need collagenases and plasminogen activator to degrade the clot and part of the ECM.[3][19] Zinc-dependent metalloproteinases digest basement membrane and ECM to allow cell migration, proliferation and angiogenesis.[38]

When macrophages and other growth factor-producing cells are no longer in a hypoxic, lactic acid-filled environment, they stop producing angiogenic factors.[20] Thus, when tissue is adequately perfused, migration and proliferation of endothelial cells is reduced. Eventually blood vessels that are no longer needed die by apoptosis.[37]

Fibroplasia and granulation tissue formation

[edit]

Simultaneously with angiogenesis, fibroblasts begin accumulating in the wound site. Fibroblasts begin entering the wound site two to five days after wounding as the inflammatory phase is ending, and their numbers peak at one to two weeks post-wounding.[19] By the end of the first week, fibroblasts are the main cells in the wound.[3] Fibroplasia ends two to four weeks after wounding.

As a model the mechanism of fibroplasia may be conceptualised as an analogous process to angiogenesis (see above) - only the cell type involved is fibroblasts rather than endothelial cells. Initially there is a latent phase where the wound undergoes plasma exudation, inflammatory decontamination and debridement. Oedema increases the wound histologic accessibility for later fibroplastic migration. Second, as inflammation nears completion, macrophage and mast cells release fibroblast growth and chemotactic factors to activate fibroblasts from adjacent tissue. Fibroblasts at this stage loosen themselves from surrounding cells and ECM. Phagocytes further release proteases that break down the ECM of neighbouring tissue, freeing the activated fibroblasts to proliferate and migrate towards the wound. The difference between vascular sprouting and fibroblast proliferation is that the former is enhanced by hypoxia, whilst the latter is inhibited by hypoxia. The deposited fibroblastic connective tissue matures by secreting ECM into the extracellular space, forming granulation tissue (see below). Lastly collagen is deposited into the ECM.

In the first two or three days after injury, fibroblasts mainly migrate and proliferate, while later, they are the main cells that lay down the collagen matrix in the wound site.[3] Origins of these fibroblasts are thought to be from the adjacent uninjured cutaneous tissue (although new evidence suggests that some are derived from blood-borne, circulating adult stem cells/precursors).[39] Initially fibroblasts utilize the fibrin cross-linking fibers (well-formed by the end of the inflammatory phase) to migrate across the wound, subsequently adhering to fibronectin.[37] Fibroblasts then deposit ground substance into the wound bed, and later collagen, which they can adhere to for migration.[15]

Granulation tissue functions as rudimentary tissue, and begins to appear in the wound already during the inflammatory phase, two to five days post wounding, and continues growing until the wound bed is covered. Granulation tissue consists of new blood vessels, fibroblasts, inflammatory cells, endothelial cells, myofibroblasts, and the components of a new, provisional extracellular matrix (ECM). The provisional ECM is different in composition from the ECM in normal tissue and its components originate from fibroblasts.[28] Such components include fibronectin, collagen, glycosaminoglycans, elastin, glycoproteins and proteoglycans.[37] Its main components are fibronectin and hyaluronan, which create a very hydrated matrix and facilitate cell migration.[31] Later this provisional matrix is replaced with an ECM that more closely resembles that found in non-injured tissue.

Growth factors (PDGF, TGF-β) and fibronectin encourage proliferation, migration to the wound bed, and production of ECM molecules by fibroblasts. Fibroblasts also secrete growth factors that attract epithelial cells to the wound site. Hypoxia also contributes to fibroblast proliferation and excretion of growth factors, though too little oxygen will inhibit their growth and deposition of ECM components, and can lead to excessive, fibrotic scarring.

Collagen deposition

[edit]

One of fibroblasts' most important duties is the production of collagen.[36]

Collagen deposition is important because it increases the strength of the wound; before it is laid down, the only thing holding the wound closed is the fibrin-fibronectin clot, which does not provide much resistance to traumatic injury.[20] Also, cells involved in inflammation, angiogenesis, and connective tissue construction attach to, grow and differentiate on the collagen matrix laid down by fibroblasts.[40]

Type III collagen and fibronectin generally begin to be produced in appreciable amounts at somewhere between approximately 10 hours[41] and 3 days,[37] depending mainly on wound size. Their deposition peaks at one to three weeks.[28] They are the predominating tensile substances until the later phase of maturation, in which they are replaced by the stronger type I collagen.

Even as fibroblasts are producing new collagen, collagenases and other factors degrade it. Shortly after wounding, synthesis exceeds degradation so collagen levels in the wound rise, but later production and degradation become equal so there is no net collagen gain.[20] This homeostasis signals the onset of the later maturation phase. Granulation gradually ceases and fibroblasts decrease in number in the wound once their work is done.[42] At the end of the granulation phase, fibroblasts begin to commit apoptosis, converting granulation tissue from an environment rich in cells to one that consists mainly of collagen.[3]

Epithelialization

[edit]

The formation of granulation tissue into an open wound allows the reepithelialization phase to take place, as epithelial cells migrate across the new tissue to form a barrier between the wound and the environment.[37] Basal keratinocytes from the wound edges and dermal appendages such as hair follicles, sweat glands and sebaceous (oil) glands are the main cells responsible for the epithelialization phase of wound healing.[42] They advance in a sheet across the wound site and proliferate at its edges, ceasing movement when they meet in the middle. In healing that results in a scar, sweat glands, hair follicles[43][44] and nerves do not form. With the lack of hair follicles, nerves and sweat glands, the wound, and the resulting healing scar, provide a challenge to the body with regards to temperature control.[44]

Keratinocytes migrate without first proliferating.[45] Migration can begin as early as a few hours after wounding. However, epithelial cells require viable tissue to migrate across, so if the wound is deep it must first be filled with granulation tissue.[46] Thus the time of onset of migration is variable and may occur about one day after wounding.[47] Cells on the wound margins proliferate on the second and third day post-wounding in order to provide more cells for migration.[28]

If the basement membrane is not breached, epithelial cells are replaced within three days by division and upward migration of cells in the stratum basale in the same fashion that occurs in uninjured skin.[37] However, if the basement membrane is ruined at the wound site, reepithelization must occur from the wound margins and from skin appendages such as hair follicles and sweat and oil glands that enter the dermis that are lined with viable keratinocytes.[28] If the wound is very deep, skin appendages may also be ruined and migration can only occur from wound edges.[46]

Migration of keratinocytes over the wound site is stimulated by lack of contact inhibition and by chemicals such as nitric oxide.[48] Before they begin to migrate, cells must dissolve their desmosomes and hemidesmosomes, which normally anchor the cells by intermediate filaments in their cytoskeleton to other cells and to the ECM.[23] Transmembrane receptor proteins called integrins, which are made of glycoproteins and normally anchor the cell to the basement membrane by its cytoskeleton, are released from the cell's intermediate filaments and relocate to actin filaments to serve as attachments to the ECM for pseudopodia during migration.[23] Thus keratinocytes detach from the basement membrane and are able to enter the wound bed.[35]

Before they begin migrating, keratinocytes change shape, becoming longer and flatter and extending cellular processes like lamellipodia and wide processes that look like ruffles.[31] Actin filaments and pseudopodia form.[35] During migration, integrins on the pseudopod attach to the ECM, and the actin filaments in the projection pull the cell along.[23] The interaction with molecules in the ECM through integrins further promotes the formation of actin filaments, lamellipodia, and filopodia.[23]

Epithelial cells climb over one another in order to migrate.[42] This growing sheet of epithelial cells is often called the epithelial tongue.[45] The first cells to attach to the basement membrane form the stratum basale. These basal cells continue to migrate across the wound bed, and epithelial cells above them slide along as well.[45] The more quickly this migration occurs, the less of a scar there will be.[49]

Fibrin, collagen, and fibronectin in the ECM may further signal cells to divide and migrate. Like fibroblasts, migrating keratinocytes use the fibronectin cross-linked with fibrin that was deposited in inflammation as an attachment site to crawl across.[25][31][42]

A scab covering a healing wound

As keratinocytes migrate, they move over granulation tissue but stay underneath the scab, thereby separating the scab from the underlying tissue.[42][47] Epithelial cells have the ability to phagocytize debris such as dead tissue and bacterial matter that would otherwise obstruct their path. Because they must dissolve any scab that forms, keratinocyte migration is best enhanced by a moist environment, since a dry one leads to formation of a bigger, tougher scab.[25][37][42][50] To make their way along the tissue, keratinocytes must dissolve the clot, debris, and parts of the ECM in order to get through.[47][51] They secrete plasminogen activator, which activates plasminogen, turning it into plasmin to dissolve the scab. Cells can only migrate over living tissue,[42] so they must excrete collagenases and proteases like matrix metalloproteinases (MMPs) to dissolve damaged parts of the ECM in their way, particularly at the front of the migrating sheet.[47] Keratinocytes also dissolve the basement membrane, using instead the new ECM laid down by fibroblasts to crawl across.[23]

As keratinocytes continue migrating, new epithelial cells must be formed at the wound edges to replace them and to provide more cells for the advancing sheet.[25] Proliferation behind migrating keratinocytes normally begins a few days after wounding[46] and occurs at a rate that is 17 times higher in this stage of epithelialization than in normal tissues.[25] Until the entire wound area is resurfaced, the only epithelial cells to proliferate are at the wound edges.[45]

Growth factors, stimulated by integrins and MMPs, cause cells to proliferate at the wound edges. Keratinocytes themselves also produce and secrete factors, including growth factors and basement membrane proteins, which aid both in epithelialization and in other phases of healing.[52] Growth factors are also important for the innate immune defense of skin wounds by stimulation of the production of antimicrobial peptides and neutrophil chemotactic cytokines in keratinocytes.

Keratinocytes continue migrating across the wound bed until cells from either side meet in the middle, at which point contact inhibition causes them to stop migrating.[31] When they have finished migrating, the keratinocytes secrete the proteins that form the new basement membrane.[31] Cells reverse the morphological changes they underwent in order to begin migrating; they reestablish desmosomes and hemidesmosomes and become anchored once again to the basement membrane.[23] Basal cells begin to divide and differentiate in the same manner as they do in normal skin to reestablish the strata found in reepithelialized skin.[31]

Contraction

[edit]

Contraction is a key phase of wound healing with repair. If contraction continues for too long, it can lead to disfigurement and loss of function.[32] Thus there is a great interest in understanding the biology of wound contraction, which can be modelled in vitro using the collagen gel contraction assay or the dermal equivalent model.[27][53]

Contraction commences approximately a week after wounding, when fibroblasts have differentiated into myofibroblasts.[54] In full thickness wounds, contraction peaks at 5 to 15 days post wounding.[37] Contraction can last for several weeks[46] and continues even after the wound is completely reepithelialized.[3] A large wound can become 40 to 80% smaller after contraction.[31][42] Wounds can contract at a speed of up to 0.75 mm per day, depending on how loose the tissue in the wounded area is.[37] Contraction usually does not occur symmetrically; rather most wounds have an 'axis of contraction' which allows for greater organization and alignment of cells with collagen.[54]

At first, contraction occurs without myofibroblast involvement.[55] Later, fibroblasts, stimulated by growth factors, differentiate into myofibroblasts. Myofibroblasts, which are similar to smooth muscle cells, are responsible for contraction.[55] Myofibroblasts contain the same kind of actin as that found in smooth muscle cells.[32]

Myofibroblasts are attracted by fibronectin and growth factors and they move along fibronectin linked to fibrin in the provisional ECM in order to reach the wound edges.[25] They form connections to the ECM at the wound edges, and they attach to each other and to the wound edges by desmosomes. Also, at an adhesion called the fibronexus, actin in the myofibroblast is linked across the cell membrane to molecules in the extracellular matrix like fibronectin and collagen.[55] Myofibroblasts have many such adhesions, which allow them to pull the ECM when they contract, reducing the wound size.[32] In this part of contraction, closure occurs more quickly than in the first, myofibroblast-independent part.[55]

As the actin in myofibroblasts contracts, the wound edges are pulled together. Fibroblasts lay down collagen to reinforce the wound as myofibroblasts contract.[3] The contraction stage in proliferation ends as myofibroblasts stop contracting and commit apoptosis.[32] The breakdown of the provisional matrix leads to a decrease in hyaluronic acid and an increase in chondroitin sulfate, which gradually triggers fibroblasts to stop migrating and proliferating.[19] These events signal the onset of the maturation stage of wound healing.

Maturation and remodeling

[edit]

When the levels of collagen production and degradation equalize, the maturation phase of tissue repair is said to have begun.[20] During maturation, type III collagen, which is prevalent during proliferation, is replaced by type I collagen.[17] Originally disorganized collagen fibers are rearranged, cross-linked, and aligned along tension lines.[31] The onset of the maturation phase may vary extensively, depending on the size of the wound and whether it was initially closed or left open,[28] ranging from approximately three days[41] to three weeks.[56] The maturation phase can last for a year or longer, similarly depending on wound type.[28]

As the phase progresses, the tensile strength of the wound increases.[28] Collagen will reach approximately 20% of its tensile strength after three weeks, increasing to 80% after 12 months. The maximum scar strength is 80% of that of unwounded skin.[57] Since activity at the wound site is reduced, the scar loses its red appearance as blood vessels that are no longer needed are removed by apoptosis.[20]

The phases of wound healing normally progress in a predictable, timely manner; if they do not, healing may progress inappropriately to either a chronic wound[7] such as a venous ulcer or pathological scarring such as a keloid scar.[58][59]

Factors affecting wound healing

[edit]

Many factors controlling the efficacy, speed, and manner of wound healing fall under two types: local and systemic factors.[2]

Local factors

[edit]
  • Moisture; keeping a wound moist rather than dry makes wound healing more rapid and with less pain and less scarring[60]
  • Mechanical factors
  • Oedema
  • Ionizing radiation
  • Faulty technique of wound closure
  • Ischemia and necrosis
  • Foreign bodies. Sharp, small foreign bodies can penetrate the skin leaving little surface wound but causing internal injury and internal bleeding. For a glass foreign body, "frequently, an innocent skin wound disguises the extensive nature of the injuries beneath".[61] First-degree nerve injury requires a few hours to a few weeks to recover.[62] If a foreign body passes by a nerve and causes first-degree nerve injury during entry, then the sensation of the foreign body or pain due to internal wounding may be delayed by a few hours to a few weeks after entry. A sudden increase in pain during the first few weeks of wound healing could be a sign of a recovered nerve reporting internal injuries rather than a newly developed infection.
  • Low oxygen tension
  • Perfusion

Systemic factors

[edit]
  • Inflammation
  • Diabetes – Individuals with diabetes demonstrate reduced capability in the healing of acute wounds. Additionally, diabetic individuals are susceptible to developing chronic diabetic foot ulcers, a serious complication of diabetes which affects 15% of people with diabetes and accounts for 84% of all diabetes-related lower leg amputations.[63] The impaired healing abilities of diabetics with diabetic foot ulcers and/or acute wounds involves multiple pathophysiological mechanisms.[64] This impaired healing involves hypoxia, fibroblast and epidermal cell dysfunction, impaired angiogenesis and neovascularization, high levels of metalloproteases, damage from reactive oxygen species and AGEs (advanced glycation end-products), decreased host immune resistance, and neuropathy.[64]
  • Nutrients – Malnutrition or nutritional deficiencies have a recognizable impact on wound healing post trauma or surgical intervention.[65] Nutrients including proteins, carbohydrates, arginine, glutamine, polyunsaturated fatty acids, vitamin A, vitamin C, vitamin E, magnesium, copper, zinc and iron all play significant roles in wound healing.[64] Fats and carbohydrates provide the majority of energy required for wound healing. Glucose is the most prominent source of fuel and it is used to create cellular ATP, providing energy for angiogenesis and the deposition of new tissues.[64] As the nutritional needs of each patient and their associated wound are complex, it is suggested that tailored nutritional support would benefit both acute and chronic wound healing.[64]
  • Metabolic diseases
  • Immunosuppression
  • Connective tissue disorders
  • Smoking – Smoking causes a delay in the speed of wound repair notably in the proliferative and inflammatory phases. It also increases the likelihood of certain complications such as wound rupture, wound and flap necrosis, decrease in wound tensile strength and infection.[64] Passive smoking also impairs a proper wound healing process.[66]
  • Age – Increased age (over 60 years) is a risk factor for impaired wound healing.[64] It is recognized that, in older adults of otherwise overall good health, the effects of aging causes a temporal delay in healing, but no major impairment with regard to the quality of healing.[67] Delayed wound healing in patients of increasing age is associated with altered inflammatory response; for example delayed T-cell infiltration of the wound with alterations in the production of chemokines, and reduced macrophage phagocytic capacity.[68]
  • Alcohol – Alcohol consumption impairs wound healing and also increases the chances of infection. Alcohol affects the proliferative phase of healing. A single unit of alcohol causes a negative effect on re-epithelialization, wound closure, collagen production and angiogenesis.[64]

In the 2000s there arose the first Mathematical models of the healing process, based on simplified assumptions and on a system of differential equations solved through MATLAB. The models show that the "rate of the healing process" appears to be "highly influenced by the activity and size of the injury itself as well as the activity of the healing agent."[69]

Research and development

[edit]

Up until about 2000, the classic paradigm of wound healing, involving stem cells restricted to organ-specific lineages, had never been seriously challenged. Since then, the notion of adult stem cells having cellular plasticity or the ability to differentiate into non-lineage cells has emerged as an alternative explanation.[1] To be more specific, hematopoietic progenitor cells (that give rise to mature cells in the blood) may have the ability de-differentiate back into hematopoietic stem cells and/or transdifferentiate into non-lineage cells, such as fibroblasts.[39]

Stem cells and cellular plasticity

[edit]

Multipotent adult stem cells have the capacity to be self-renewing and give rise to different cell types. Stem cells give rise to progenitor cells, which are cells that are not self-renewing, but can generate several types of cells. The extent of stem cell involvement in cutaneous (skin) wound healing is complex and not fully understood.[citation needed] Stem cell injection leads to wound healing primarily through stimulation of angiogenesis.[70]

It is thought that the epidermis and dermis are reconstituted by mitotically active stem cells that reside at the apex of rete ridges (basal stem cells or BSC), the bulge of hair follicles (hair follicular stem cell or HFSC), and the papillary dermis (dermal stem cells).[1] Moreover, bone marrow may also contain stem cells that play a major role in cutaneous wound healing.[39]

In rare circumstances, such as extensive cutaneous injury, self-renewal subpopulations in the bone marrow are induced to participate in the healing process, whereby they give rise to collagen-secreting cells that seem to play a role during wound repair.[1] These two self-renewal subpopulations are (1) bone marrow-derived mesenchymal stem cells (MSC) and (2) hematopoietic stem cells (HSC). Bone marrow also harbors a progenitor subpopulation (endothelial progenitor cells or EPC) that, in the same type of setting, are mobilized to aid in the reconstruction of blood vessels.[39] Moreover, it is thought that extensive injury to skin also promotes the early trafficking of a unique subclass of leukocytes (circulating fibrocytes) to the injured region, where they perform various functions related to wound healing.[1]

Wound repair versus regeneration

[edit]

An injury is an interruption of morphology and/or functionality of a given tissue. After injury, structural tissue heals with incomplete or complete regeneration.[71][72] Tissue without an interruption to the morphology almost always completely regenerates. An example of complete regeneration without an interruption of the morphology is non-injured tissue, such as skin.[73] Non-injured skin has a continued replacement and regeneration of cells which always results in complete regeneration.[73]

There is a subtle distinction between 'repair' and 'regeneration'.[1][71][72] Repair means incomplete regeneration.[71] Repair or incomplete regeneration, refers to the physiologic adaptation of an organ after injury in an effort to re-establish continuity without regards to exact replacement of lost/damaged tissue.[71] True tissue regeneration or complete regeneration,[72] refers to the replacement of lost/damaged tissue with an 'exact' copy, such that both morphology and functionality are completely restored.[72] Though after injury mammals can completely regenerate spontaneously, they usually do not completely regenerate. An example of a tissue regenerating completely after an interruption of morphology is the endometrium; the endometrium after the process of breakdown via the menstruation cycle heals with complete regeneration.[73]

In some instances, after a tissue breakdown, such as in skin, a regeneration closer to complete regeneration may be induced by the use of biodegradable (collagen-glycoaminoglycan) scaffolds. These scaffolds are structurally analogous to extracellular matrix (ECM) found in normal/un-injured dermis.[74] Fundamental conditions required for tissue regeneration often oppose conditions that favor efficient wound repair, including inhibition of (1) platelet activation, (2) inflammatory response, and (3) wound contraction.[1] In addition to providing support for fibroblast and endothelial cell attachment, biodegradable scaffolds inhibit wound contraction, thereby allowing the healing process to proceed towards a more-regenerative/less-scarring pathway. Pharmaceutical agents have been investigated which may be able to turn off myofibroblast differentiation.[75]

A new way of thinking derived from the notion that heparan sulfates are key player in tissue homeostasis: the process that makes the tissue replace dead cells by identical cells. In wound areas, tissue homeostasis is lost as the heparan sulfates are degraded preventing the replacement of dead cells by identical cells. Heparan sulfate analogues cannot be degraded by all known heparanases and glycanases and bind to the free heparin sulfate binding spots on the ECM, therefore preserving the normal tissue homeostasis and preventing scarring.[76][77][78]

Repair or regeneration with regards to hypoxia-inducible factor 1-alpha (HIF-1a). In normal circumstances after injury HIF-1a is degraded by prolyl hydroxylases (PHDs). Scientists found that the simple up-regulation of HIF-1a via PHD inhibitors regenerates lost or damaged tissue in mammals that have a repair response; and the continued down-regulation of Hif-1a results in healing with a scarring response in mammals with a previous regenerative response to the loss of tissue. The act of regulating HIF-1a can either turn off, or turn on the key process of mammalian regeneration.[79][80]

Scarless wound healing

[edit]

Scarless wound healing is a concept based on the healing or repair of the skin (or other tissue/organs) after injury with the aim of healing with subjectively and relatively less scar tissue than normally expected. Scarless healing is sometimes mixed up with the concept of scar free healing, which is wound healing that results in absolutely no scar (free of scarring) may occur naturally at some locations of the human body and research in 2025 has decoded molecular players that drive that scarless healing.[81] However, they are different concepts.

The opposite of scarless wound healing is scarification (wound healing to scar more). Historically, certain cultures consider scarification attractive;[82] however, this is generally not the case in the modern western society, in which many patients are turning to plastic surgery clinics with unrealistic expectations. Depending on scar type, treatment may be invasive (intralesional steroid injections, surgery) and/or conservative (compression therapy, topical silicone gel, brachytherapy, photodynamic therapy).[83] Clinical judgment is necessary to successfully balance the potential benefits of the various treatments available against the likelihood of a poor response and possible complications resulting from these treatments. Many of these treatments may only have a placebo effect, and the evidence base for the use of many current treatments is poor.[84]

Since the 1960s, comprehension of the basic biologic processes involved in wound repair and tissue regeneration have expanded due to advances in cellular and molecular biology.[85] Currently, the principal goals in wound management are to achieve rapid wound closure with a functional tissue that has minimal aesthetic scarring.[86] However, the ultimate goal of wound healing biology is to induce a more perfect reconstruction of the wound area. Scarless wound healing only occurs in mammalian foetal tissues[87] and complete regeneration is limited to lower vertebrates, such as salamanders, and invertebrates.[88] In adult humans, injured tissue are repaired by collagen deposition, collagen remodelling and eventual scar formation, where fetal wound healing is believed to be more of a regenerative process with minimal or no scar formation.[87] Therefore, foetal wound healing can be used to provide an accessible mammalian model of an optimal healing response in adult human tissues. Clues as to how this might be achieved come from studies of wound healing in embryos, where repair is fast and efficient and results in essentially perfect regeneration of any lost tissue.

The etymology of the term scarless wound healing has a long history.[89][90][91] In print the antiquated concept of scarless healing was brought up in the early 20th century and appeared in a paper published in the London Lancet. This process involved cutting at a surgical slant to the skin surface, rather than at a right angle it; the process was described in various newspapers.[89][90][91]

Cancer

[edit]

After inflammation, restoration of normal tissue integrity and function is preserved by feedback interactions between diverse cell types mediated by adhesion molecules and secreted cytokines. Disruption of normal feedback mechanisms in cancer threatens tissue integrity and enables a malignant tumor to escape the immune system.[92][93] An example of the importance of the wound healing response within tumors is illustrated in work by Howard Chang and colleagues at Stanford University studying breast cancers.[8]

Oral collagen supplements

[edit]

Preliminary results are promising for the short and long-term use of oral collagen supplements for wound healing and skin aging. Oral collagen supplements also increase skin elasticity, hydration, and dermal collagen density. Collagen supplementation is generally safe with no reported adverse events. Further studies are needed to elucidate medical use in skin barrier diseases such as atopic dermatitis and to determine optimal dosing regimens.[94]

Wound dressings

[edit]

Modern wound dressing to aid in wound repair has undergone considerable research and development in recent years. Scientists aim to develop wound dressings which have the following characteristics:[95]

  • Provide wound protection
  • Remove excess exudate
  • Possess antimicrobial properties
  • Maintain a humid environment
  • Have high permeability to oxygen
  • Are easily removed from a wound site
  • Possess non-anaphylactic characteristics

Cotton gauze dressings have been the standard of care, despite their dry properties that can adhere to wound surfaces and cause discomfort upon removal. Recent research has set out to improve cotton gauze dressings to bring them closer in line to achieve modern wound dressing properties, by coating cotton gauze wound dressing with a chitosan/Ag/ZnO nanocomposite. These updated dressing provide increase water absorbency and improved antibacterial efficacy.[95]

Wound cleansing

[edit]

Dirt or dust on the surface of the wound, bacteria, tissue that has died, and fluid from the wound may be cleaned. The evidence supporting the most effective technique is not clear and there is insufficient evidence to conclude whether cleaning wounds is beneficial for promoting healing or whether wound cleaning solutions (polyhexamethylene biguanide, aqueous hydrogen peroxide, etc.) are better than sterile water or saline solutions to help venous leg ulcers heal.[96] It is uncertain whether the choice of cleaning solution or method of application makes any difference to venous leg ulcer healing.[96]  

Simulating wound healing from a growth perspective

[edit]

Considerable effort has been devoted to understanding the physical relationships governing wound healing and subsequent scarring, with mathematical models and simulations developed to elucidate these relationships.[97] The growth of tissue around the wound site is a result of the migration of cells and collagen deposition by these cells. The alignment of collagen describes the degree of scarring; basket-weave orientation of collagen is characteristic of normal skin, whereas aligned collagen fibers lead to significant scarring.[98] It has been shown that the growth of tissue and extent of scar formation can be controlled by modulating the stress at a wound site.[99]

The growth of tissue can be simulated using the aforementioned relationships from a biochemical and biomechanical point of view. The biologically active chemicals that play an important role in wound healing are modeled with Fickian diffusion to generate concentration profiles. The balance equation for open systems when modeling wound healing incorporates mass growth due to cell migration and proliferation. Here the following equation is used:

Dtρ0 = Div (R) + R0,

where ρ represents mass density, R represents a mass flux (from cell migration), and R0 represents a mass source (from cell proliferation, division, or enlargement).[100] Relationships like these can be incorporated into an agent-based models, where the sensitivity to single parameters such as initial collagen alignment, cytokine properties, and cell proliferation rates can be tested.[101]

Wound closure intentions

[edit]

Successful wound healing is dependent on various cell types, molecular mediators and structural elements.[102]

Primary intention

[edit]

Primary intention is the healing of a clean wound without tissue loss.[102] In this process, wound edges are brought together, so that they are adjacent to each other (re-approximated). Wound closure is performed with sutures (stitches), staples, or adhesive tape or glue.

Primary intention can only be implemented when the wound is precise and there is minimal disruption to the local tissue and the epithelial basement membrane, e.g. surgical incisions.[103]

This process is faster than healing by secondary intention.[102] There is also less scarring associated with primary intention, as there are no large tissue losses to be filled with granulation tissue, though some granulation tissue will form.[102]

Secondary intention

[edit]
  • Secondary intention is implemented when primary intention is not possible because of significant tissue damage or loss, usually due to the wound having been created by major trauma.[103]
  • The wound is allowed to granulate.
  • Surgeon may pack the wound with a gauze or use a drainage system.
  • Granulation results in a broader scar.
  • Healing process can be slow due to presence of drainage from infection.
  • Wound care must be performed daily to encourage wound debris removal to allow for granulation tissue formation.
  • Using antibiotics or antiseptics for the surgical wound healing by secondary intention is controversial.[105]
  • Examples: gingivectomy, gingivoplasty, tooth extraction sockets, poorly reduced fractures, burns, severe lacerations, pressure ulcers.
  • There is insufficient evidence that the choice of dressings or topical agents affects the secondary healing of wounds.[106]
  • There is lack of evidence for the effectiveness of negative pressure wound therapy in wound healing by secondary intention.[107]

Tertiary intention

[edit]

(Delayed primary closure):

  • The wound is initially cleaned, debrided and observed, typically 4 or 5 days before closure.
  • The wound is purposely left open.
  • Examples: healing of wounds by use of tissue grafts.

If the wound edges are not reapproximated immediately, delayed primary wound healing transpires. This type of healing may be desired in the case of contaminated wounds. By the fourth day, phagocytosis of contaminated tissues is well underway, and the processes of epithelization, collagen deposition, and maturation are occurring. Foreign materials are walled off by macrophages that may metamorphose into epithelioid cells, which are encircled by mononuclear leukocytes, forming granulomas. Usually the wound is closed surgically at this juncture, or the scab is eaten, and if the "cleansing" of the wound is incomplete, chronic inflammation can ensue, resulting in prominent scarring.

Overview of involved growth factors

[edit]

Following are the main growth factors involved in wound healing:

Growth factor Abbreviation Main origins Effects
Epidermal growth factor EGF
Transforming growth factor-α TGF-α
  • Activated macrophages
  • T-lymphocytes
  • Keratinocytes
  • Hepatocyte and epithelial cell proliferation
  • Expression of antimicrobial peptides
  • Expression of chemotactic cytokines
Hepatocyte growth factor HGF
Vascular endothelial growth factor VEGF
  • Mesenchymal cells
  • Vascular permeability
  • Endothelial cell proliferation
Platelet derived growth factor PDGF
  • Platelets
  • Macrophages
  • Endothelial cells
  • Smooth muscle cells
  • Keratinocytes
Fibroblast growth factor 1 and 2 FGF-1, −2
  • Macrophages
  • Mast cells
  • T-lymphocytes
  • Endothelial cells
  • Fibroblasts
  • Fibroblast chemotaxis
  • Fibroblast and keratinocyte proliferation
  • Keratinocyte migration
  • Angiogenesis
  • Wound contraction
  • Matrix (collagen fibers) deposition
Transforming growth factor-β TGF-β
  • Platelets
  • T-lymphocytes
  • Macrophages
  • Endothelial cells
  • Keratinocytes
  • Smooth muscle cells
  • Fibroblasts
  • Granulocyte, macrophage, lymphocyte, fibroblast and smooth muscle cell chemotaxis
  • TIMP synthesis
  • Angiogenesis
  • Fibroplasia
  • Matrix metalloproteinase production inhibition
  • Keratinocyte proliferation
Keratinocyte growth factor KGF
  • Keratinocytes
  • Keratinocyte migration, proliferation and differentiation
Unless else specified in boxes, then reference is:[108]

Complications of wound healing

[edit]

The major complications are many:

  1. Deficient scar formation: Results in wound dehiscence or rupture of the wound due to inadequate formation of granulation tissue.
  2. Excessive scar formation: Hypertrophic scar, keloid, desmoid.
  3. Exuberant granulation (proud flesh).
  4. Deficient contraction (in skin grafts) or excessive contraction (in burns).
  5. Pigmentary changes such as Postinflammatory hyperpigmentation
  6. Others: Dystrophic calcification, painful scars, incisional hernia

Other complications can include infection and Marjolin's ulcer.

Biologics, skin substitutes, biomembranes and scaffolds

[edit]

Advancements in the clinical understanding of wounds and their pathophysiology have commanded significant biomedical innovations in the treatment of acute, chronic, and other types of wounds. Many biologics, skin substitutes, biomembranes and scaffolds have been developed to facilitate wound healing through various mechanisms.[109] This includes a number of products under the trade names such as Epicel, Laserskin, Transcyte, Dermagraft, AlloDerm/Strattice, Biobrane, Integra, Apligraf, OrCel, GraftJacket and PermaDerm.[110]

See also

[edit]

Notes and references

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Wound healing is a dynamic, multifaceted through which the body restores the integrity of damaged and underlying tissues following , involving orchestrated cellular migration, proliferation, and extracellular remodeling to reestablish a protective barrier and functional tissue architecture. This is essential for , as the skin serves as the primary barrier against pathogens and environmental stressors, and disruptions in can lead to chronic wounds affecting millions worldwide, with annual U.S. treatment costs estimated at over $25 billion as of 2024. The wound healing cascade unfolds in four overlapping phases: hemostasis, inflammation, proliferation, and remodeling, each characterized by specific cellular and molecular events that must be precisely coordinated for optimal repair. begins immediately upon , involving , platelet activation, and clot formation to achieve control and provide a provisional matrix for subsequent cellular infiltration. The inflammatory phase follows, dominated by the recruitment of neutrophils, macrophages, and lymphocytes to clear , combat , and release cytokines and growth factors that transition the wound to repair. During the proliferative phase, fibroblasts, endothelial cells, and collaborate to form , promote for nutrient delivery, and facilitate re-epithelialization through epidermal cell and proliferation. Finally, the remodeling phase, which can extend for months to years, involves the reorganization of the , cross-linking, and of excess cells to enhance tensile strength, though the resulting typically achieves only 70-80% of the original tissue's strength. Successful wound healing depends on intrinsic and extrinsic factors, including adequate oxygenation, nutrition, and absence of comorbidities and risk factors such as diabetes, immunosuppression, smoking, and vaping (electronic cigarette use), which impair wound healing through mechanisms including prolonged inflammation, impaired angiogenesis, reduced tissue oxygenation due to nicotine-induced vasoconstriction and other tobacco-related effects, and lead to non-healing ulcers. Pathological outcomes, including hypertrophic scars or keloids in susceptible individuals, arise from dysregulated remodeling, while chronic wounds persist due to persistent inflammation and bacterial biofilms. Advances in understanding these mechanisms have informed therapeutic strategies, such as bioactive dressings, therapies, and , aimed at accelerating repair and minimizing scarring.

Fundamentals

Definition and Significance

Wound healing is the body's dynamic and orchestrated biological response to tissue , encompassing a complex series of events that aim to restore the integrity, structure, and function of damaged tissues through the replacement of devitalized cellular structures and . This process involves coordinated interactions among cellular, humoral, and molecular components to repair the wound site, often resulting in the formation of new tissue that approximates the original architecture. The understanding of wound healing has evolved significantly over millennia, beginning with ancient practices documented in the , an Egyptian surgical treatise dating back to approximately 2500 BCE, which describes observations of injuries and early treatment methods without reliance on explanations. Subsequent advancements occurred through Greco-Roman contributions, but modern insights emerged in the with the advent of , enabling visualization of cellular processes, and the introduction of techniques by , which revolutionized infection control in wound management. Wound healing plays a critical role in preventing by facilitating the removal of contaminants and pathogens during the inflammatory response, while also restoring the skin's to protect against external threats such as and microbial invasion. Its significance is underscored by the global burden of impaired healing, with chronic wounds affecting approximately 7 million individuals annually in the United States, particularly impacting Medicare beneficiaries (about 8.2 million cases), leading to substantial morbidity and an economic impact exceeding $28 billion in treatment costs each year as of 2024. A fundamental aspect of wound healing is the distinction between repair and regeneration: repair typically culminates in formation, where fibrous tissue replaces the original structure without fully restoring function, whereas true regeneration achieves complete restoration of the pre-injury tissue architecture and functionality, a observed more readily in certain organisms but limited in adult humans.

Wound Classification

Wounds are classified according to multiple criteria, including , depth, and healing potential, to guide clinical assessment and management by identifying underlying causes and expected healing trajectories. This categorization helps differentiate wounds that heal predictably from those requiring intervention for persistent barriers.

Classification by Etiology

Wounds are often categorized by their cause, which influences the healing process and associated risks. Traumatic wounds result from mechanical injury and include abrasions, which involve superficial scraping of the skin surface; lacerations, characterized by irregular tearing of tissue; punctures from sharp objects; and avulsions, where tissue is partially or fully torn away. Surgical wounds arise from intentional incisions during procedures, typically clean and linear, though they can become contaminated if involving the respiratory, alimentary, or genitourinary tracts. Burn wounds stem from thermal, chemical, electrical, or radiation exposure, with thermal burns subclassified as scalds (hot liquids), contact burns (hot surfaces), flame burns, or others, each presenting unique tissue damage patterns. Chronic wounds, by contrast, develop from prolonged underlying conditions and include diabetic ulcers (neuropathic foot lesions), pressure sores (from sustained pressure over bony prominences), and vascular ulcers.

Classification by Depth

Depth classification assesses the extent of tissue involvement, which correlates with healing time and scarring potential. Superficial wounds affect only the , the outermost skin layer, often appearing as or minor without blistering. Partial-thickness wounds extend into the but spare deeper structures, manifesting as blisters, weeping, or moist red bases, and may involve superficial or deep dermal layers. Full-thickness wounds penetrate through the entire into subcutaneous fat or beyond, potentially reaching muscle, , or , and typically present with dry, leathery or necrotic tissue, requiring more intensive intervention.

Acute versus Chronic Wounds

Acute wounds occur suddenly from identifiable and progress through normal stages within 4 to 6 weeks, assuming no complications. In contrast, chronic wounds persist beyond 3 months or fail to advance despite appropriate care, often due to factors like ischemia, , or comorbidities that disrupt repair mechanisms. This distinction highlights healing potential, with acute wounds generally resolving predictably and chronic ones necessitating targeted therapy for underlying etiologies such as poor or .

Special Types

Venous ulcers, typically located on the medial ankle, arise from and often present as shallow, exudative lesions with irregular borders and surrounding pigmentation. Arterial ulcers, resulting from peripheral ischemia, occur on toes or feet with punched-out edges, pale bases, and minimal due to compromised flow. Wounds in the differ markedly from wounds, healing more rapidly with reduced , minimal scarring, and faster re-epithelialization, attributed to intrinsic differences in behavior and transcriptional profiles that promote resolution over .

Stages of Wound Healing

Hemostasis

is the immediate response to tissue in wound healing, aimed at arresting loss and establishing a provisional matrix for subsequent repair processes. This phase begins within seconds of vascular damage and typically lasts from minutes to a few hours, involving coordinated vascular, platelet, and plasma protein responses. The primary goal is to form a stable clot that seals the wound while minimizing excessive . The process initiates with rapid vascular constriction, occurring within seconds of , where in the vessel walls contracts to reduce flow and limit hemorrhage. This is triggered by local neurogenic reflexes, endothelial cell release of , and from aggregating platelets. Concurrently, circulating platelets are activated by exposure to subendothelial and at the site. Activation leads to platelet adhesion, shape change from discoid to spherical, and , releasing (ADP) and to recruit and aggregate additional platelets. This results in the formation of a primary hemostatic plug, which temporarily seals the breach within approximately 1-3 minutes. Secondary hemostasis reinforces the through the cascade, a series of enzymatic reactions that generate insoluble . The cascade comprises the intrinsic pathway, activated by contact of with negatively charged surfaces like , and the extrinsic pathway, initiated by (factor III) expressed from damaged cells binding to factor VII. These pathways converge at the activation of by their respective tenase complexes, forming the prothrombinase complex (factors Xa, Va, calcium, and phospholipids) that converts prothrombin (factor II) to (factor IIa). plays a central role by cleaving soluble fibrinogen into monomers, which spontaneously polymerize into a mesh that entraps platelets and red blood cells, stabilizing the clot over 20-60 minutes via factor XIII-mediated cross-linking. As the fibrin clot forms, activated platelets release chemotactic factors such as and , which signal the onset of the inflammatory phase by attracting neutrophils and monocytes to clear and pathogens. This transition ensures sets the foundation for immune-mediated repair without extending into proliferative activities.

Inflammation

The inflammation phase of wound healing follows and serves as an immune-mediated cleanup process, where immune cells infiltrate the wound site to eliminate pathogens, , and damaged tissue remnants from the initial clotting cascade. This phase typically peaks at 24-48 hours post-injury and lasts 4-6 days in acute wounds, ensuring a controlled response that prevents while preparing the site for tissue regeneration. Following the transient of , the vascular response shifts to , mediated by released from mast cells and prostaglandins from damaged tissues, which increase and enable into the wound bed. This permeability change facilitates the rapid recruitment of immune cells, marking the onset of active . Polymorphonuclear neutrophils (PMNs), also known as neutrophils, act as in this phase, arriving within hours of via chemotactic signals from the clotting remnants. These cells perform to engulf and debris, while their oxidative burst generates to kill pathogens and break down necrotic material. Although essential for early defense, excessive PMN activity can contribute to tissue damage if not resolved promptly. Macrophages begin arriving around day 2-3, differentiating from recruited monocytes and taking over as dominant effectors after the PMN influx subsides. These cells continue of remaining debris and apoptotic neutrophils, while releasing pro-inflammatory such as TNF-α and IL-1 to amplify the and orchestrate the transition to the proliferation phase. Through this cytokine signaling, macrophages help regulate the inflammatory milieu, ensuring clearance without prolonged damage. The decline of inflammation occurs through resolution mechanisms, including anti-inflammatory signals like IL-10 from shifting macrophage phenotypes and programmed apoptosis of excess neutrophils and macrophages, which clears the wound site for subsequent repair. This apoptotic process, often induced by macrophages themselves, prevents chronic inflammation and maintains the balance essential for efficient healing.

Proliferation

The proliferative phase of wound healing, also known as the tissue formation stage, typically spans from day 4 to day 21 post-injury and overlaps with the waning of the inflammatory response. This phase focuses on rebuilding the wound site through the synthesis of new connective tissue and coverage of the injured area, transitioning from immune-mediated cleanup to structural repair. As inflammation subsides, macrophages play a key role in signaling the onset of proliferative events by releasing growth factors that recruit reparative cells. A central process in this phase is fibroplasia, involving the migration and proliferation of fibroblasts into the provisional matrix of the wound bed. These fibroblasts synthesize and deposit components of , a pink, vascularized matrix rich in type III , , and proteoglycans, which provides a scaffold for further tissue regeneration. formation ensures the wound is filled with a supportive framework that facilitates subsequent cellular activities. Angiogenesis occurs concurrently, driven primarily by vascular endothelial growth factor (VEGF) secreted by hypoxic cells and macrophages, which induces endothelial cell sprouting from surrounding vessels. This results in the formation of new capillary networks that deliver essential oxygen and nutrients to the avascular wound environment, sustaining the high metabolic demands of proliferating cells. Without adequate angiogenesis, granulation tissue development is impaired, highlighting its critical role in proliferative success. Epithelialization begins with the migration of from the viable at the wound margins, advancing across the surface to restore the epidermal barrier. This process involves keratinocyte proliferation at the edges, basement membrane reformation through and IV deposition, and eventual reestablishment of like hair follicles in superficial wounds. Epithelial coverage is essential for preventing and marking the transition to maturation. Wound contraction contributes significantly to reducing the defect size, mediated by specialized myofibroblasts that express alpha-smooth muscle actin and generate contractile forces to pull wound edges inward. In open wounds, this mechanism can decrease the wound area by up to 80-90%, minimizing the volume of tissue that needs to be filled by granulation. Myofibroblast activity is regulated by transforming growth factor-beta (TGF-β) and mechanical tension within the extracellular matrix. Collagen deposition ramps up during this phase, with fibroblasts initially producing type III fibrils that form a loose, flexible network integrated into the granulation tissue. These undergo enzymatic cross-linking primarily via lysyl oxidase, an enzyme that oxidizes residues to create stable covalent bonds, enhancing matrix tensile strength without yet achieving the organized structure of mature . This early collagen framework supports cellular migration and sets the stage for later refinement.

Remodeling

The remodeling phase represents the final stage of wound healing, characterized by the maturation and reorganization of the to enhance tissue functionality and strength. This process refines the formed during proliferation, transitioning the wound into a stable through controlled degradation and synthesis. Remodeling typically begins around weeks 2 to 3 after and can extend for months to years, with the wound achieving peak tensile strength of approximately 80% of the original tissue by 1 year. During this extended period, the undergoes continuous structural adjustments to optimize durability while minimizing excess material. A key aspect of remodeling involves collagen reorganization, where the initial type III collagen, which provides temporary flexibility, is progressively replaced by stronger through enzymatic degradation mediated by matrix metalloproteinases (MMPs). MMPs, including collagenases like MMP-1 and MMP-8, break down disorganized fibers, allowing fibroblasts to realign and cross-link new type I fibers, thereby increasing overall tensile strength. This shift enhances the scar's mechanical properties, making it more resistant to stress. Concurrent with matrix refinement, via reduces the population of excess cells, including fibroblasts, endothelial cells, and myofibroblasts, to decrease cellularity and vascularity in the maturing . Myofibroblasts, which drove contraction in earlier phases, undergo as mechanical tension eases, preventing over-contraction and promoting a leaner tissue architecture. This cellular cleanup is regulated by factors such as transforming growth factor-beta and , ensuring the integrates efficiently with surrounding tissue. Wound tensile strength develops gradually during remodeling, starting from about 3% of original strength by week 1 and rising asymptotically toward its maximum. This curve reflects the balance between ongoing collagen synthesis and degradation, with rapid gains in the first few months followed by slower improvements. Scar formation ultimately depends on the equilibrium between extracellular matrix synthesis and degradation, mediated by MMPs and their inhibitors (TIMPs). When this balance is maintained, the result is a mature, avascular scar with aligned, cross-linked collagen bundles that provide sufficient strength without excessive fibrosis. Disruptions in this equilibrium can alter scar quality, underscoring the phase's role in long-term tissue integrity.

Cellular and Molecular Mechanisms

Key Cells Involved

Platelets are among the first responders to vascular injury, rapidly aggregating to form a that prevents excessive blood loss during the initial phase of wound healing. They also serve as reservoirs for growth factors, including (PDGF), which is released upon to recruit additional cells and initiate subsequent repair processes. Neutrophils arrive shortly after platelets, comprising the earliest infiltrating leukocytes in the inflammation phase, where they perform phagocytosis to clear debris, bacteria, and damaged tissue from the wound site. In cases of infection, neutrophils deploy neutrophil extracellular traps (NETs)—web-like structures of DNA and antimicrobial proteins—to entrap and kill pathogens, though excessive NET formation can prolong inflammation and impair healing. Macrophages play a pivotal role across multiple phases, transitioning from pro-inflammatory M1 phenotypes that amplify immune responses and in early to pro-resolving M2 phenotypes that promote tissue repair, , and (ECM) deposition during proliferation and remodeling. This polarization is dynamically regulated, with recent 2025 research highlighting how the wound modulates macrophage phenotypes; for instance, commensal can shift macrophages toward M2 dominance to accelerate diabetic wound closure by reshaping microbial communities and reducing . Fibroblasts are essential producers of ECM components, such as and , during the proliferation phase, providing structural support for new tissue formation and facilitating contraction. Under stimulation, they differentiate into myofibroblasts, which express alpha-smooth muscle (α-SMA) to generate contractile forces that close the and align ECM fibers during remodeling. Endothelial cells drive in the proliferation phase by forming new blood vessels to supply oxygen and nutrients to the healing tissue. This process involves specialized tip cells that lead sprout invasion in response to gradients of (VEGF), while adjacent stalk cells proliferate and elongate to form vessel tubes, ensuring coordinated vascular network development. Keratinocytes, the primary cells of the epidermis, re-epithelialize the wound surface during proliferation by migrating from the edges to cover the defect and restore . They also secrete , such as human β-defensins, which provide innate defense against and support a sterile environment conducive to healing.

Growth Factors and Signaling Pathways

Growth factors are essential polypeptides that orchestrate the cellular responses during wound healing by binding to specific receptors on target cells, thereby activating intracellular signaling cascades that regulate proliferation, migration, differentiation, and (ECM) production. These factors are secreted by various cells, including platelets, macrophages, and fibroblasts, and their coordinated release ensures progression through the healing phases. Among the major growth factors, (PDGF) plays a pivotal role in recruiting fibroblasts to the wound site through , promoting their proliferation and initiating formation. Transforming growth factor-beta (TGF-β) is a multifunctional with three isoforms—TGF-β1, TGF-β2, and TGF-β3—that predominantly drive ECM synthesis by stimulating fibroblasts to produce and other matrix components, while also modulating and . (VEGF), primarily VEGF-A, is critical for , inducing endothelial cell proliferation and migration to form new blood vessels essential for oxygen delivery to the healing tissue. (EGF) and fibroblast growth factors (FGFs), such as FGF-2, stimulate epithelial cell proliferation and migration, facilitating re-epithelialization and differentiation at the wound edges. The temporal expression of these growth factors aligns with specific healing phases, as summarized in the following table:
Growth FactorPrimary Phases InvolvedKey Roles
PDGF and Platelet degranulation; and proliferation
TGF-β and ProliferationECM deposition;
VEGFProliferationEndothelial ; vascularization
EGF/FGFProliferation and RemodelingEpithelial migration; proliferation
Signaling pathways downstream of these growth factors are highly specific and interconnected. The TGF-β/Smad pathway is central to , where binding to TGF-β receptors leads to of Smad2/3 proteins, which translocate to the nucleus to regulate genes involved in synthesis and differentiation. For VEGF, activation of receptors (VEGFRs), particularly VEGFR-2, triggers activity that promotes endothelial cell survival, migration, and vessel sprouting through downstream effectors like PI3K/Akt and MAPK pathways. The affinity of growth factor-receptor interactions is quantified by the KdK_d, defined as
Kd=[L][R][LR]K_d = \frac{[L][R]}{[LR]}
where [L] is the free concentration, [R] is the free receptor concentration, and [LR] is the -receptor complex concentration; lower KdK_d values indicate higher binding affinity, influencing signaling efficiency in the wound microenvironment.
Crosstalk between pathways enhances regulatory precision, such as the hypoxia-inducible factor-1α (HIF-1α)-mediated induction of VEGF expression under low oxygen conditions, which amplifies during the proliferative phase by stabilizing HIF-1α and promoting its transcriptional activity on the VEGF promoter. This interaction exemplifies how environmental cues integrate with signaling to adapt responses.

Influencing Factors

Local Factors

Local factors within the wound microenvironment significantly influence the healing process by modulating cellular activities and tissue responses at the site of injury. Oxygen tension plays a pivotal role, as hypoxia—characterized by low of oxygen (pO₂ below 30 mmHg)—impairs by inhibiting endothelial cell proliferation, migration, and (VEGF) expression, thereby delaying formation during the proliferation phase. In contrast, normoxic or hyperoxic conditions support neovascularization; hyperbaric oxygen therapy (HBOT), which elevates tissue pO₂ to 1000-2000 mmHg at 2-3 atmospheres absolute, enhances deposition and epithelialization as an adjunctive modality by counteracting hypoxic effects without addressing underlying causes. Collagen synthesis is oxygen-dependent, as the enzymes prolyl and lysyl hydroxylase require molecular oxygen to hydroxylate proline and lysine residues in collagen precursors, essential for stable collagen triple-helix formation and deposition. In ischemic wounds, tissue hypoxia impairs this hydroxylation process, leading to reduced collagen deposition and delayed healing. Infection represents another critical local determinant, where elevated bacterial loads greater than 10⁵ colony-forming units per gram (CFU/g) of tissue indicate critical transitioning to , prolonging the inflammatory phase and impeding progression to proliferation and remodeling. Biofilms, structured communities of encased in an extracellular polymeric matrix, exacerbate delays by shielding pathogens from immune responses and antimicrobials. Moisture balance is equally vital; dry environments promote formation and desiccated cell death, while optimal moist conditions facilitate keratinocyte migration and reduce healing time. George D. Winter's foundational 1962 study on porcine wounds showed that epithelialization under moist occlusive dressings occurred at 0.6-0.8 mm/day, approximately three times faster than the 0.2-0.3 mm/day in air-exposed dry wounds. While moist wound healing promotes epithelialization, reduces pain, and supports cellular activity, it does not directly supply oxygen; in severely ischemic wounds, interventions to improve oxygenation such as revascularization or hyperbaric oxygen therapy are often necessary alongside moist healing to address underlying hypoxia. Dressings that manage —absorbing excess to prevent maceration while maintaining hydration—optimize this balance to support autolysis and autolytic . Mechanical stresses, including shear forces at wound edges from movement or pressure, affect contraction and alignment, potentially accelerating closure at moderate levels but disrupting epithelial resurfacing and increasing scarring risk under excessive tension. Local influences microbial proliferation and activity, with acute wounds starting near neutral ( 7.4) but optimally shifting to mildly acidic ( 5.5-6.5) to enhance activity and peptide release. Dressings such as hydrogels or hydrocolloids can lower through production or buffering, while also enabling local nutrient delivery; for instance, advanced formulations incorporate zinc or to bolster synthesis and defenses directly at the site. Zinc, applied topically via such dressings, promotes cell proliferation through DNA and protein synthesis, supports collagen production for enhanced tissue strength, regulates local inflammation by facilitating immune cell activity and free radical clearance, enhances antimicrobial defenses to prevent infections, and supports epithelial regeneration to facilitate wound closure. These local effects complement the systemic roles of zinc in wound healing.

Systemic Factors

Systemic factors encompass physiological, pathological, and environmental influences originating from the entire body that modulate the wound healing process. These include nutritional status, chronic diseases, hormonal changes, medications, and emerging roles of the , all of which can either support or hinder the coordinated progression through , , proliferation, and remodeling phases. Nutritional deficiencies represent a major systemic barrier to effective wound healing, particularly through impacts on synthesis and immune function. Protein malnutrition impairs proliferation and deposition, leading to weakened wound tensile strength and delayed closure. Optimizing intake to 1.2–2.0 g/kg/day supports repair processes. , or ascorbic acid, is essential for the of and residues in procollagen, enabling stable triple-helix formation; supplementation if deficient enhances collagen synthesis. Similarly, disrupts enzymatic processes in and cell division, reducing and activity while prolonging . Adequate zinc levels promote cell proliferation via DNA and protein synthesis as well as collagen production for tissue strength; regulate inflammation by aiding platelet and immune cell release and free radical clearance; enhance immunity to prevent infections; and support epithelial regeneration to close wounds. Supplementation addresses these deficits in deficient individuals. Arginine supplementation, particularly if deficient, further aids healing by promoting angiogenesis and immune modulation. Clinical evidence indicates that optimizing these nutritional elements can shorten healing time by weeks. In children with acute superficial wounds such as abrasions (scrapes), a balanced diet supports recovery by supplying key nutrients: protein for tissue repair, vitamin C for collagen synthesis, vitamin A for epithelial growth, and zinc for immune function and cell proliferation. Recommended foods include lean meats, fish, eggs, dairy products (milk, yogurt, cheese), beans, nuts, citrus fruits, berries, carrots, leafy greens, and whole grains. Adequate caloric intake and fluid consumption are essential to meet increased metabolic demands and maintain hydration for optimal cellular function. It is advisable to limit or avoid sugary foods and beverages, desserts, candy, processed snacks, fatty meats, and refined carbohydrates (e.g., white bread), as these provide minimal nutritional value and may impair healing by promoting inflammation or displacing nutrient-dense foods. Comorbidities such as , , and electronic cigarette use (vaping) profoundly disrupt systemic support for healing. In , impairs , , and production, resulting in persistent and failure to transition to proliferation; controlling blood glucose improves perfusion and reduces inflammation to accelerate healing. Smoking and vaping impair healing primarily through nicotine-induced , which reduces and nutrient delivery to the bed; smoking additionally involves binding to to cause tissue hypoxia akin to poisoning, collectively delaying and epithelialization. Quantitative studies show that smoking significantly delays wound healing, including a 1.1-day delay in corneal epithelial healing (mean 5.9 days in smokers vs. 4.8 days in nonsmokers), up to 27.7 days longer time to bone union, and a 2.2-fold increased risk of delayed or non-union. Vaping impairs wound healing similarly to smoking, causing comparable tissue necrosis and delayed healing (equivalent to smoking a pack of cigarettes per day when vaping one cartridge daily), primarily due to nicotine's vasoconstrictive effects, though specific quantitative delays are less commonly quantified for vaping. Cessation of smoking and avoidance of vaping mitigate these effects and reduce complication rates. Aging and hormonal imbalances further compromise healing capacity. In the elderly, reduced stems from diminished (VEGF) expression and endothelial progenitor cell mobilization, leading to poorer formation and slower closure rates compared to younger individuals. Corticosteroids, whether endogenous in stress responses or exogenous in therapy, suppress the inflammatory phase by inhibiting release and leukocyte recruitment, which can delay activity and synthesis if administered chronically. Certain medications, notably agents, exert broad immunosuppressive effects that delay all healing phases. Cytotoxic drugs inhibit cellular , reduce leukocyte counts, and impair platelet function, increasing risk and prolonging while stunting proliferation and remodeling. As of 2025, dysbiosis in the gut has emerged as a systemic factor influencing via the gut-skin axis. Alterations in gut microbiota composition, often seen in diabetic patients, promote through increased permeability and translocation of pro-inflammatory metabolites, which exacerbate local wound chronicity by hindering resolution of the inflammatory phase and .

Management and Closure

Closure Intentions

Wound closure intentions refer to the strategic approaches clinicians use to approximate edges or facilitate healing based on the 's condition, level, and risk factors. These methods—primary, secondary, and tertiary —guide whether to close the immediately, leave it open, or delay closure, influencing healing speed, risk, and scarring outcomes. Primary healing involves direct apposition of clean, well-aligned edges using sutures, staples, or adhesives to minimize the gap and promote rapid closure. This method is ideal for surgical incisions or traumatic wounds with minimal tissue loss and low risk, as it reduces the need for formation and results in the least scarring. However, it carries a higher risk if underlying is present, potentially leading to formation or dehiscence. In contrast, secondary intention healing allows the wound to remain open, relying on natural processes such as formation, wound contraction by myofibroblasts, and epithelial migration from the edges to fill the defect. This approach is preferred for contaminated, , or irregular wounds with significant tissue loss, as it permits drainage of and reduces risk by avoiding entrapment of . Additionally, secondary intention healing is often preferred for palmar wounds to preserve the unique properties of glabrous palmar skin, which are difficult to replicate with grafts or flaps. However, this approach can result in greater contraction and potential complications such as contractures if not managed properly. Drawbacks include longer healing times, greater production, and increased scarring due to contraction. Tertiary intention, also known as delayed primary closure, combines elements of the other methods by initially managing the as open or packed to control , followed by closure after 4–6 days once subsides and begins. It is commonly used for high-risk wounds, such as those with gross contamination or in patients prone to poor , balancing the benefits of drainage with eventual edge approximation to limit scarring. While effective for infection control, it prolongs the overall process compared to primary intention. For wounds healing by secondary intention, re-epithelialization typically proceeds at a rate of 1–2 mm per day from the wound margins, though this can vary with factors like wound size and patient health.

Dressings and Cleansing Techniques

Wound cleansing is a fundamental step in supportive care to remove debris, , and remnants of previous dressings while minimizing trauma to the wound bed. Normal saline irrigation is the preferred method for routine cleansing due to its isotonic properties, which effectively clean without causing to healing tissues. Antiseptics such as are not recommended for routine use due to that can impair formation and delay healing by damaging fibroblasts and ; povidone-iodine, while effective against , shows no evidence of delaying healing and may be used judiciously in contaminated wounds but offers no routine benefit over saline. , the removal of necrotic or devitalized tissue, is often integrated into cleansing protocols and can be achieved through autolytic or enzymatic methods. Autolytic relies on the body's endogenous enzymes and moisture to selectively liquefy and break down non-viable tissue, typically facilitated by moisture-retentive dressings and suitable for non-infected wounds. Enzymatic involves the topical application of proteolytic agents, such as collagenase, to chemically dissolve necrotic material, offering a non-surgical option for patients with comorbidities that preclude mechanical methods. Wound dressings play a critical role in creating an optimal healing environment by protecting the , managing moisture, and addressing specific local factors like levels. Dressings are categorized into passive, interactive, and bioactive types based on their interaction with the . Passive dressings, such as or , primarily provide a non-occlusive barrier to cover the and absorb minimal , but they do not actively influence the healing process. Interactive dressings, including hydrogels and hydrocolloids, maintain a moist interface to promote autolysis and epithelialization while managing moderate through hydration or absorption. For biopsy wounds, moist healing is preferred over dry healing as it promotes faster recovery, reduces scarring, and prevents thick scab formation; this can be achieved by applying petroleum jelly and covering with an adhesive bandage, per AAD recommendations. However, moist wound healing environments support epithelialization and cellular activity but do not address tissue hypoxia in ischemic wounds, where adjunctive oxygenation therapies may be required. Bioactive dressings incorporate agents, such as ionic silver, to reduce in colonized or infected without promoting widespread resistance when used judiciously. Advanced techniques like (NPWT) enhance the healing environment through sub-atmospheric pressure applied via a sealed interface, which mechanically stabilizes the wound, promotes formation, and removes interstitial fluid. A key mechanism of NPWT is the reduction of periwound by drawing out excess fluid and inflammatory mediators, thereby improving local and decreasing tissue swelling. This therapy is particularly beneficial for chronic or high-exudate wounds, accelerating closure rates compared to standard dressings. Selection of dressings and cleansing methods is guided by wound characteristics, including exudate volume and infection status, to balance moisture, prevent maceration, and control bioburden. For low-exudate wounds without infection, interactive moisture-retentive options suffice, while high-exudate or infected sites require absorbent or antimicrobial dressings to mitigate risks like biofilm formation. In 2025, antimicrobial stewardship has gained prominence in wound care to curb resistance, emphasizing targeted use of agents like silver only in confirmed infections and routine microbial surveillance to optimize outcomes. Emerging microbiome-targeted cleansers, such as those incorporating probiotics or stabilized hypochlorous acid, which selectively modulate wound microbiota without broad-spectrum disruption, represent a promising advance, supported by recent models and trials evaluating their efficacy against biofilms.

Complications

Delayed Healing and Infections

Delayed wound healing refers to the impaired progression through the normal phases of wound healing, where wounds become trapped in a state of persistent , often described as a "senescent" condition that hinders transition to proliferation and remodeling. This chronic inflammatory state is characterized by prolonged and activity, leading to excessive release and tissue degradation without effective repair. Local factors such as poor and systemic factors like or immunosuppression can exacerbate this risk by promoting an environment conducive to stalled . Bacterial biofilms play a central role in delaying healing by forming protective matrices that shield pathogens from host immune responses and antibiotics, thereby sustaining and preventing formation. These biofilms induce a senescent-like in fibroblasts and , reducing their proliferative capacity and production. In chronic wounds, which are defined as those failing to heal within 30 days despite appropriate care, healing often stalls at the inflammatory or early proliferative phases due to this biofilm-mediated persistence. Wound infections frequently involve common pathogens such as and , which are often co-isolated in polymicrobial communities that enhance virulence and resistance. Clinical signs of infection include localized (redness), swelling, increased pain, and purulent discharge (), which serve as a for further microbial proliferation. If untreated, these can lead to systemic spread, manifesting as fever, , or , particularly in vulnerable patients with chronic wounds. Studies indicate that polymicrobial biofilms, involving interactions between S. aureus and P. aeruginosa, contribute to chronicity by altering microbial and amplifying inflammatory signals, with prevalence estimated at 60-80% in non-healing wounds. Diagnosis of delayed healing and infections relies on wound swabs for microbial culture to identify pathogens and guide targeted therapy, alongside biomarkers such as elevated matrix metalloproteinase-9 (MMP-9) levels in wound fluid, which predict poor healing outcomes by indicating excessive proteolytic activity. Elevated MMP-9 concentrations correlate with stalled progression and biofilm presence, offering a quantifiable measure beyond visual assessment. Emerging AI-driven diagnostics, including image analysis tools for detecting subtle infection signs like irregular erythema patterns, show promise for early detection, improving accuracy over traditional methods in studies as of 2025.

Excessive Scarring

Excessive scarring in wound healing arises from pathological over-remodeling of the , resulting in hypertrophic scars or keloids that impair function and aesthetics. Hypertrophic scars are confined to the boundaries of the original , appearing as raised, red, and firm lesions that may regress over time with proper . In contrast, keloids extend beyond the wound margins, forming irregular, tumor-like growths that do not spontaneously improve and often recur after treatment. Keloids show a strong , occurring more frequently in individuals with darker skin tones, such as those of African, Asian, or descent. The involves dysregulated transforming growth factor-beta (TGF-β) signaling, which promotes prolonged proliferation and excessive deposition, leading to an imbalance in matrix remodeling. In both hypertrophic scars and keloids, TGF-β isoforms, particularly TGF-β1 and TGF-β2, are overexpressed, driving differentiation and inhibiting matrix metalloproteinases that normally degrade excess . This results in disorganized, nodular bundles—type III in early stages transitioning to type I—contrasting with the balanced remodeling in normal wounds. Inflammatory cytokines and mechanical tension further exacerbate hyperactivity, perpetuating the fibrotic response. Risk factors include wound tension, particularly in areas like the chest, shoulders, or earlobes, as well as a history of prior scarring or family predisposition, with incidence rates ranging from 4-16% in high-risk populations such as burn patients or those undergoing surgical incisions in susceptible sites. Clinically, these scars often present with pruritus, , and hyperemia, potentially leading to contractures that restrict joint mobility and cause functional impairment. Particularly in mobile areas such as the palm, wounds healing by secondary intention may develop scar tightness and potential contractures during the active scar remodeling phase, typically lasting 6-12 months and extending up to 2 years in some cases. Full scar maturation often takes 12-18 months to 2 years, during which tightness can persist if unmanaged. Early intervention with massage, splinting, exercises, and positioning reduces tightness and prevents severe contractures in these areas. Assessment typically employs the Vancouver Scar Scale, which evaluates pigmentation, vascularity, pliability, and height to quantify severity and monitor progression. Recent investigations into offer promise for scarless healing by targeting genetic drivers of , though clinical translation remains in early stages.

Research and Advances

Regenerative and Stem Cell Approaches

Regenerative approaches to wound healing aim to shift from the typical mammalian repair process, which culminates in fibrotic scarring, toward true tissue regeneration that restores original architecture and function. In adult mammals, wound closure involves , proliferation, and remodeling phases that often lead to collagen-rich scars impairing tissue mechanics. By contrast, early fetal mammalian wounds and those in regenerative models like the achieve scarless healing through coordinated cellular plasticity and minimal . , particularly the HoxD cluster, play a pivotal role in limb regeneration by recapitulating developmental patterns to specify proximal-distal identity in the , a process disrupted in mammalian scarring where such positional cues fail to promote full regeneration. Scarless healing in fetal wounds is characterized by a distinct profile, notably the dominance of 3 (TGF-β3) over pro-fibrotic isoforms TGF-β1 and TGF-β2, which suppresses excessive deposition and promotes ordered tissue reconstitution. This TGF-β3 predominance reduces and hyaluronan synthesis, mimicking regenerative environments observed in axolotls where wounds re-epithelialize rapidly without persistence. Exogenous TGF-β3 application in adult models has replicated aspects of this scarless by modulating types I and III ratios. Early clinical trials showed promise for TGF-β3-enriched therapies in enhancing fetal-like repair in adult incisions, but phase III trials failed to confirm efficacy. Stem cell therapies leverage cellular and plasticity to foster regeneration. Mesenchymal stem cells (MSCs), derived from or , exert primary effects through secretome-mediated paracrine actions, including secretion of cytokines, growth factors like (VEGF), and extracellular vesicles that enhance , re-epithelialization, and formation while attenuating . These paracrine mechanisms outperform direct cell differentiation, as MSCs survive poorly in hypoxic wound beds but their factors persist to modulate the microenvironment. Preclinical and early clinical studies of MSCs in wounds have shown accelerated closure and reduced scarring through paracrine effects, including signaling. Induced pluripotent stem cells (iPSCs) offer autologous regenerative potential by reprogramming patient somatic cells into pluripotent states for deriving -specific lineages, bypassing immune rejection risks associated with allogeneic sources. iPSC-generated and fibroblasts form stratified equivalents that integrate into , promoting vascularization and reformation in preclinical diabetic models. A 2025 preclinical study showed that iPSC-derived mesenchymal stem cells enhanced regeneration and accelerated closure in a porcine model without formation. Recent 2025 advances include CRISPR-Cas9 editing to suppress pro-fibrotic genes like TGF-β1 in preclinical models, promoting scarless healing. Links between chronic wounds and underscore regenerative challenges, as persistent in non-healing ulcers fosters pre-malignant microenvironments through dysregulated pathways shared with tumorigenesis. Chronic wounds, often termed "wounds that do not heal," exhibit genomic instability and epithelial hyperplasia akin to , with signaling as a key mediator activating survival and proliferative genes in both contexts. inhibition in wound models reduces while curbing pro-oncogenic , suggesting dual therapeutic potential for regenerative strategies targeting this pathway to prevent malignant progression in at-risk ulcers.

Biomaterials and Emerging Technologies

Biomaterials play a pivotal role in modern wound healing by providing scaffolds that mimic the , promote tissue regeneration, and deliver therapeutic agents. Acellular dermal matrices, such as AlloDerm, derived from cadaveric human , serve as structural scaffolds that facilitate host cell infiltration and vascularization without eliciting strong immune responses. Clinical applications of AlloDerm have demonstrated its efficacy in reconstructing full-thickness wounds, including burns and surgical defects, by supporting neodermis formation over several weeks. Bioengineered skin substitutes like Apligraf represent advanced cellularized biomaterials, consisting of a bovine lattice populated with human and fibroblasts to form a bilayer resembling native . Apligraf has shown superior rates in chronic venous leg ulcers and ulcers compared to standard compression therapy, with complete closure achieved in 56% of cases within 12 weeks. These substitutes integrate with the wound bed to accelerate re-epithelialization and reduce scarring, particularly in non-healing wounds recalcitrant to conventional treatments. Emerging smart wound dressings incorporate embedded sensors to monitor key parameters such as , , and in real-time, enabling dynamic adjustments to the wound microenvironment. In 2024, advancements in electrochemical and colorimetric sensors integrated into hydrogel-based dressings allowed for detection of biomarkers, with prototypes demonstrating sensitivity from 4.5 to 8.5 and levels correlating to management. These intelligent systems, such as those using liquid diode mechanisms, provide continuous feedback to clinicians, reducing dressing changes by up to 50% and promoting a moist environment. Three-dimensional (3D) bioprinting has revolutionized custom graft fabrication by layering bioinks composed of hydrogels, living cells, and growth factors to create patient-specific skin constructs. Recent developments utilize extrusion-based bioprinting with gelatin-methacryloyl bioinks incorporating fibroblasts and epidermal growth factor, yielding scaffolds with over 90% cell viability and pore sizes of 200-500 μm for optimal nutrient diffusion. These printed grafts have accelerated wound closure in preclinical diabetic models by 40%, integrating seamlessly with host tissue while minimizing contraction. Brief integration with stem cells enhances vascularization in these bioprinted structures, further supporting complex wound repair. Nanotherapeutics enhance wound healing through via nanoparticles, which improve and reduce systemic . Silver nanoparticles (AgNPs), typically 10-50 nm in size, exhibit potent activity by disrupting bacterial membranes, making them ideal for incorporation into dressings to combat formation in chronic wounds. Studies from 2023-2025 highlight AgNP-loaded scaffolds that sustained silver ion release for 14 days, achieving over 99% reduction in while promoting deposition and epithelialization. Other nanoparticles, such as lipid-based carriers for growth factors like VEGF, have shown controlled release profiles extending up to 30 days, enhancing in ischemic wounds. Telemedicine and (AI) technologies facilitate remote wound monitoring, with meta-analyses indicate that telemedicine and AI technologies can reduce healing times through image-based assessments and predictive algorithms. AI-driven platforms analyze smartphone-captured wound images to quantify area, depth, and risk with 95% accuracy, enabling personalized treatment adjustments. A 2025 study on AI-integrated bioelectronic bandages reported 25% faster closure in preclinical models by optimizing electrical stimulation based on real-time and data. These tools, including theranostic systems like TheraHeal, support continuous diagnostics and on-demand therapy delivery, particularly benefiting remote or underserved populations.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.